Scientific Sessions 2025  /  Imaging for Precision and Outcomes in Structural Heart Disease Procedures: An AHA Journals Session  /  Decoding MAC: High Risk Imaging Features and Their Impact on Outcomes for transcatheter therapies
Logo

American Heart Association

  85
  0

Final ID:

Decoding MAC: High Risk Imaging Features and Their Impact on Outcomes for transcatheter therapies

  • Cremer, Paul  ( Northwestern University , Chicago , Illinois , United States )
  • Hays, Allison  ( Johns Hopkins , Clarksville , Maryland , United States )
  • Wang, Andrew  ( Duke University Hospital , Durham , North Carolina , United States )
  • Cavender, Matthew  ( University of North Carolina , Chapel Hill , North Carolina , United States )
  • Gillam, Linda  ( MORRISTOWN MEDICAL CENTER , Morristown , New Jersey , United States )
  • Watanabe, Nozomi  ( University of Miyazaki , Miyazaki , Japan )
  • Fearon, William  ( STANFORD UNIVERSITY , Stanford , California , United States )
    • Author Disclosures:
    Paul Cremer: DO have relevant financial relationships ; Consultant:Kiniksa:Active (exists now) ; Consultant:PFizer:Past (completed) ; Consultant:Boston Scientific:Active (exists now) ; Consultant:MonteRosa :Active (exists now) ; Consultant:Ventyx:Active (exists now) ; Consultant:CardiolRx:Active (exists now) | Allison Hays: DO NOT have relevant financial relationships | Andrew Wang: DO have relevant financial relationships ; Consultant:Bristol Myers Squibb:Past (completed) ; Independent Contractor:ICON:Active (exists now) ; Research Funding (PI or named investigator):Abbott Vascular:Active (exists now) ; Research Funding (PI or named investigator):Edgewise:Expected (by end of conference) ; Research Funding (PI or named investigator):Lexicon:Expected (by end of conference) ; Speaker:Bristol Myers Squibb:Past (completed) ; Research Funding (PI or named investigator):Cytokinetics:Active (exists now) ; Research Funding (PI or named investigator):Bristol Myers Squibb:Active (exists now) | Matthew Cavender: No Answer | Linda Gillam: DO have relevant financial relationships ; Advisor:Medtronic:Past (completed) ; Advisor:Medtronic:Active (exists now) ; Advisor:Krinsky:Past (completed) | Nozomi Watanabe: DO have relevant financial relationships ; Research Funding (PI or named investigator):Pfizer Inc.:Active (exists now) | William Fearon: DO have relevant financial relationships ; Researcher:Abbott Vascular:Active (exists now) ; Individual Stocks/Stock Options:HeartFlow:Active (exists now) ; Consultant:Edwards Lifesciences:Active (exists now) ; Consultant:ShockWave:Active (exists now) ; Researcher:Medtronic:Active (exists now) ; Researcher:CathWorks:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Imaging for Precision and Outcomes in Structural Heart Disease Procedures: An AHA Journals Session

Sunday, 11/09/2025 , 08:00AM - 09:15AM

Cardiovascular Seminar

More abstracts on this topic:
Transcatheter Options for TR: A Closer Look at RV-Driven Strategies

Kaneko Tsuyoshi, Hahn Rebecca

Aortic Regurgitation Detection and Treatment: What are we missing and future directions in treatment

Welt Frederick, Fearon William

More abstracts from these authors:
Diagnostic ability of mid-coronary artery wall echogenicity in the initial diagnosis of Kawasaki Disease

Yamashita Naoto, Kodama Yoshihiko, Moritake Hiroshi, Watanabe Nozomi

Panel

Gillam Linda

You have to be authorized to contact abstract author. Please, Login
Not Available